| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.025 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0032 | 1 |